logo

ATRC

AtriCure·NASDAQ
--
--(--)
--
--(--)
1.69 / 10
Underperform

AtriCure's fundamental profile is concerning: key metrics such as Revenue-MV (-0.5205), Net income-Revenue (-0.1668), and Cash-MV (-0.6719) place the stock in historically underperforming quartiles, while only Net profit / Total profit (%) (105.438) and Net profit attributable to parent company shareholders / Net profit (%) (100) score well. The overall fundamental score of 1.7/10 underscores financial vulnerabilities that outweigh the few positive factors.

Fundamental(1.69)SentimentTechnical

Analysis Checks(4/10)

Revenue-MV
Value-0.52
Score0/3
Weight16.78%
1M Return-3.84%
ROA (%)
Value-2.12
Score1/3
Weight2.79%
1M Return-0.54%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight7.69%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight10.86%
1M Return-2.55%
Cash-UP
Value-0.17
Score2/3
Weight18.74%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-2.83
Score1/3
Weight2.79%
1M Return-0.54%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight8.67%
1M Return-1.95%
Asset-MV
Value-0.50
Score1/3
Weight3.02%
1M Return-0.63%
Cash-MV
Value-0.67
Score1/3
Weight20.59%
1M Return-5.64%
Net profit / Total profit (%)
Value105.44
Score2/3
Weight8.07%
1M Return-1.71%
Is ATRC fundamentally strong?
  • ATRC scores 1.69/10 on fundamentals and holds a Premium valuation at present. Backed by its -2.82% ROE, -5.55% net margin, -64.12 P/E ratio, 3.87 P/B ratio, and 26.51% earnings growth, these metrics solidify its Underperform investment rating.